Prevalence of Factor V Leiden Mutation in Non-European Populations

Summary

A difference in the prevalence of venous thromboembolism (TE) in major human groups has been described and an uneven distribution of FV Leiden mutation over the world has recently been reported.

We investigated FV Leiden mutation in 584 apparently healthy sub#jects mostly from populations different from those previously investi#gated: 170 Europeans (Spanish, Italians), 101 sub-saharan Africans (Fon, Bariba, Berba, Dendi), 115 Asians (Indonesians, Chinese, Tharus), 57 Amerindians (Cayapa), 84 Afroamericans (Rio Cayapa, Viche), and 57 Ethiopians (Amhara, Oromo).

The mutation was detected in only 1/115 Asian (Tharu) and in 5/170 Europeans (4 Italians, 1 Spanish).

These data confirm that in non-Europeans the prevalence of FV mutation is at least 7 times lower than in Europeans and provide indirect evidence of a low prevalence not only of the FV Leiden gene but also of other genes leading to more severe thrombophilia. Finally, findings from the literature together with those pertaining to this study clearly show a marked heterogeneity among Europeans.

• References

• 1 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van der VeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 2 Ferrer-Antunes C, Palmeiro A, Green F, Rosa H, Feliciano B, Silva E. Polymorphisms of fibrinogen, factor VII and factor V genes. Comparison of allele frequencies in different ethnic groups. Thromb Haemost 1995; 73: 1379 (abstr.)
• 3 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
• 4 Takamiya O. APC-resistance and Mnl I genotype (Gin 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
• 5 Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation Factor V Leiden mutation may have a racial background. Thromb Haemost 1995; 74: 1381
• 6 Cunningham JGE, Yong NK. The incidence of postoperative deep vein thrombosis in Malaysia. Br J Surg 1974; 61: 482-483
• 7 Chumnijarakij T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet 1975; 01: 1357-1358
• 8 Hwang WS. The rarity of pulmonary thromboembolism in Asians. Singapore Med J 1968; 09: 269-279
• 9 Woo KS, Tse LKK, Tse CY, Metreweli C, Vallance-Owen J. The prevalence and pattern of pulmonary thromboembolism in the Chinese in Hongkong. Int J Cardiol 1988; 20: 373-380
• 10 World Health Organization. World health statistical annual. (1993) and (1994)
• 11 Pepe G, Rickards O, Jodice C, Modiano G. Allele and haplotype frequency distribution of the EcoRI, Rsal and MspI COL1A2 RFLPs among various human populations. Hum Biol 1995; 06: 905-920
• 12 Rickards O. Analysis of the region V mitochondrial marker in two Black communities of Ecuador, and in their parental populations. Human Evolution 1995; 10: 05-16
• 13 Sambrook J, Frotsch EF, Maniatis T. In: Molecular cloning. Ford N, Nolan C, Ferguson M. eds. New York: Cold Spring Harbor Laboratory Press, NY; 1989. pp 9.16-9.19
• 14 Mari D, Mannucci PM, Duca F, Bertolini S, Franceschi C. Mutant factor V (Arg 506Gln) in healthy centenarians. Lancet 1996; 1347-1044
• 15 Chaida C, Gialeraki A, Tsoukala C, Mandalki T. Prevalence of the FVQ506 mutation in the Hellenic population. Thromb Haemost 1996; 76: 127
• 16 Passarino G, Semino O, Pepe G, Shrestha SL, Modiano G, Santachiara Benerecetti AS. MtDNA polymorphisms among Tharus of Eastern Terai (Nepal). Gene Geog 1992; 06: 139-147
• 17 Arruda VR, Annichino-Bizzacchi JM, Costa F, Reitsma PH. Factor V Leiden (FVQ 506) is common in a Brazilian population. Thromb Haemost 1995; 73: 1367 (abstr.)
• 18 Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR. High prevalence of a mutation in the factor V gene within the U.K. population:relationship to activated protein C resistance and familial thrombosis. BrJHaemat 1994; 88: 219-222
• 19 Aschka I, Krey S, Bergmann F, Budde U, Eberl W, Eckhof-Donovan S, Kreuz W, Nowak-Gottl U, Plendl H, Schobess R, Schneppenheim R. Prevalence of APC-resistance in children. Thromb Haemost 1995; 73: 1121 (abstr.)
• 20 Schroder W, Koessling M, Wulff K, Wehnert M, Hermann FH. World distribution of factor V Leiden mutation. Lancet (letter) 1996; 347: 58-59
• 21 de MaatMPM, Kluft C, Jespersen J, Gram J. World distribution of factor V Leiden mutation. Lancet (letter) 1996; 347: 58
• 22 Lee DH, Henderson P, Blajchman MA. Prevalence of factor V Arg506 →Gln in a blood donor population. Thromb Haemost 1995; 73: 950 (abstr.)
• 23 van BockxmeerFM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V. Nature Medicine 1995; 01: 185
• 24 Hassan MA, Rahman EA, Rahman IA. Prostatectomy and deep vein thrombosis in Sudanese patients. Br J Surg 1974; 61: 650-652
• 25 Osime U. Incidence of postoperative deep vein thrombosis in Nigerians using¹²⁵I-labelled fibrinogen. BMJ 1978; 03: 1607
• 26 Joffe SN. Racial incidence of postoperative deep vein thrombosis in South Africa. BrJ Surg 1974; 61: 982-983
• 27 Gore I, Hirst AE, Tanaka K. Myocardial infarction and thromboembolism. Arch Intern Med 1964; 113: 323-330
• 28 Thomas WA, Davies JNP, O’Neal RM, Dimakulangan AA. Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. Am J Cardiol 1960; 01: 41-47
• 29 Martinelli I, Landi G, Merati G, Celia R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 1996; 75: 393-394